Literature DB >> 15104

Further evaluation of the discriminative effects of morphine in the rat.

H E Shannon, S G Holtzman.   

Abstract

Rats were trained in a two-choice discrete trial avoidance paradigm to discriminate between saline and 3.0 mg/kg of morphine. Behavior was considered to be under stimulus ocntrol when the rats completed at least 90% of the trials in a 20-trial session on the morphine-appropriate choice lever after receiving morphine and when they completed at least 90% of the trials on the saline-appropriate choice lever after receiving saline. The discriminative effects of morphine, measured by responding on the morphine-appropriate lever, were then evaluated by determining the dose-response characteristics of representative narcotic analgesics, analgesics with mixed agonist and narcotic antagonist properties and nonopioid psychoactive drugs. Eight narcotic analgesics each produced dose-related responding on the morphine-appropriate lever. The relative potency for producing discriminative effects equivalent to those produced by 3.0 mg/kg of morphine ranged form etonitazene = 1000 x morphine to propoxyphene = 0.0175 x morphine. Of the narcotic antagonist analgesics tested, butorphanol and nalmexone produced discriminative effects equivalent to those of the morphine training dose whereas nalorphine, levallorphan, oxilorphan, nalbuphine and ketocyclazocine did not. The nonopioid psychoactive drugs, mescaline, ketamine, physostigmine and scopolamine, also failed to produce discriminative effect equivalent to those produced by 3.0 mg/kg of morphine. These results confirm and extend our previous findings that of those drugs which have also been evaluated in man, discriminative effects equivalent to the training dose of morphine are produced uniquely by narcotic analgesics and narcotic antagonists which produce morphine-like subjective effects. These results are compatible with the hypothesis that the properties of morphine which enable it to function as a discriminative stimulus in the rat are analogous to those responsible for producing subjective effects in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15104

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.

Authors:  K W Locke; B Gorney; M Cornfeldt; S Fielding
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

Review 3.  Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.

Authors:  B Levi Bolin; Joseph L Alcorn; Anna R Reynolds; Joshua A Lile; William W Stoops; Craig R Rush
Journal:  Curr Top Behav Neurosci       Date:  2018

4.  Environmental modification of tolerance to morphine discriminative stimulus properties in rats.

Authors:  C A Sannerud; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Discriminative stimulus properties of intravenous morphine in the rat.

Authors:  L G Frey; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

Review 6.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

Authors:  N Joharchi; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Species differences in the relative analgesic potencies of some classical opiates and opioid peptides.

Authors:  J I Székely; E Miglécz; S Bajusz
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.

Authors:  S G Holtzman; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

10.  Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.

Authors:  M Ohno; T Yamamoto; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.